2025
Social Determinants of Health and Healthcare Utilization in Infants With Bronchopulmonary Dysplasia
Urbach H, Ostfeld‐Johns S, McCollum S, Weiss P, Kandil S, Brumer E. Social Determinants of Health and Healthcare Utilization in Infants With Bronchopulmonary Dysplasia. Pediatric Pulmonology 2025, 60: e71153. PMID: 40504047, DOI: 10.1002/ppul.71153.Peer-Reviewed Original ResearchConceptsSocial determinants of healthChildhood Opportunity IndexArea Deprivation IndexHealthcare utilizationED visitsImpact of social determinants of healthSocial determinants of health variablesInfluence of social determinants of healthEmergency departmentAssociated with fewer ED visitsAssociated with increased ED visitsHigh-deprivation neighborhoodsDeterminants of healthBronchopulmonary dysplasiaAdverse health outcomesMediation analysisDeprivation indexHealthcare useSocial determinantsNo significant associationHealth outcomesFollow-upHospital utilizationNeighborhood disadvantageRacial/Ethnic DifferencesDetection of pulmonary hypertension in preterm infants with bronchopulmonary dysplasia using oxygen saturation data
Ramanand P, Indic P, Gentle S, Ambalavanan N. Detection of pulmonary hypertension in preterm infants with bronchopulmonary dysplasia using oxygen saturation data. Pediatric Research 2025, 1-8. PMID: 39915610, DOI: 10.1038/s41390-025-03891-8.Peer-Reviewed Original ResearchDetection of pulmonary hypertensionBronchopulmonary dysplasiaPreterm infantsPulmonary hypertensionClinical risk factorsOxygen saturation dataBedside markersPresence of patent ductus arteriosusRisk factorsSignificant clinical risk factorsPatent ductus arteriosusIncreased risk of mortalityMultivariate logistic regression modelIdentification of PHPresence of PHRisk of mortalityOxygen saturation variabilityDuctus arteriosusClinical courseBackgroundPulmonary hypertensionClinical featuresPretermLogistic regression modelsAssociated PHIncreased riskThe fungal microbiota modulate neonatal oxygen-induced lung injury
Martin I, Silverberg M, Abdelgawad A, Tanaka K, Halloran B, Nicola T, Myers E, Desai J, White C, Karabayir I, Akbilgic O, Tipton L, Gentle S, Ambalavanan N, Peters B, Vu L, Jain V, Lal C, Cormier S, Pierre J, Jilling T, Talati A, Willis K. The fungal microbiota modulate neonatal oxygen-induced lung injury. Microbiome 2025, 13: 24. PMID: 39871397, PMCID: PMC11773857, DOI: 10.1186/s40168-025-02032-x.Peer-Reviewed Original ResearchConceptsBronchopulmonary dysplasiaLung injury severityLung injuryDevelopment of bronchopulmonary dysplasiaSeverity of lung injuryAugmented lung injuryMorbidities of prematurityVery preterm infantsOxygen-induced lung injuryChronic lung diseaseIntestinal microbiomeMicrobiome of infantsPotential therapeutic strategyPreterm infantsNeonatal microbiomePremature infantsPremature neonatesInjury severityMurine modelNeonatal healthLung diseaseMouse modelTherapeutic strategiesLoss of function approachesFungal communities
2024
Improving Time to Goals of Care Discussions in Invasively Ventilated Preterm Infants.
Gentle S, Cohen C, Carlo W, Winter L, Hallman M. Improving Time to Goals of Care Discussions in Invasively Ventilated Preterm Infants. 2024, 154 PMID: 39359206, PMCID: PMC11524032, DOI: 10.1542/peds.2024-066585.Peer-Reviewed Original ResearchConceptsPostmenstrual ageBronchopulmonary dysplasiaPreterm infantsTracheostomy placementWeeks' PMA.Identifying preterm infantsWeeks postmenstrual ageBPD infantsTracheostomy dependenceInvasive ventilationGOC discussionsVentilatory requirementsTracheostomyVentilator liberationInfantsHospital dischargeMultidisciplinary conferenceQuality improvement initiativesWeeksChart analysisUniversity of AlabamaSmart aimStatistical process control chartsProcess control chartsControl chart analysisAchieved oxygen saturations and risk for bronchopulmonary dysplasia with pulmonary hypertension in preterm infants
Gentle S, Singh A, Travers C, Nakhmani A, Carlo W, Ambalavanan N. Achieved oxygen saturations and risk for bronchopulmonary dysplasia with pulmonary hypertension in preterm infants. Archives Of Disease In Childhood 2024, 109: 941-947. PMID: 38937062, PMCID: PMC11503043, DOI: 10.1136/archdischild-2024-327014.Peer-Reviewed Original ResearchConceptsBronchopulmonary dysplasia-associated pulmonary hypertensionOxygen saturation indexSurvival statusPreterm infantsPulmonary hypertensionHigher FiOLt;29 weeks' gestationFraction of inspired oxygenWeeks postmenstrual ageSingle-centre studyNon-invasive predictorCase-control studyPostmenstrual ageWeeks gestationBronchopulmonary dysplasiaRespiratory supportNon-survivorsInfantsOxygen saturationPatient outcomesPretermSurvivalHypertensionWeeksPredictorsQuality Improvement Initiative Enhances Outpatient Pediatric Pulmonology Follow-up for Premature Infants with Bronchopulmonary Dysplasia
Brumer E, Godse S, Chandrasekar L, Kizilirmak T, Blythe E, Gozzo Y, Peterec S, Kandil S, Grossman M, Chen L, Weiss P, Sheares B. Quality Improvement Initiative Enhances Outpatient Pediatric Pulmonology Follow-up for Premature Infants with Bronchopulmonary Dysplasia. Pediatric Quality And Safety 2024, 9: e736. PMID: 38854502, PMCID: PMC11161285, DOI: 10.1097/pq9.0000000000000736.Peer-Reviewed Original ResearchSevere bronchopulmonary dysplasiaBronchopulmonary dysplasiaPremature infantsFollow-upClassification of bronchopulmonary dysplasiaDiagnosis of bronchopulmonary dysplasiaYale-New Haven Children's HospitalBronchopulmonary dysplasia severityFollow-up of childrenPulmonary follow-upStandard treatment optionPercentage of patientsRespiratory-related morbidityPremature babiesInternational Classification of DiseasesAccuracy of diagnosisTreatment optionsCorrect diagnosisChildren's HospitalQuality improvement initiativesQuality improvement projectClassification of diseasesMedical recordsPercentage of appointmentsElectronic medical records737 Echocardiographic screening for bronchopulmonary dysplasia associated pulmonary hypertension: when, how often, and does it impact outcomes?
Gentle S, Carlo W, Ambalavanan N. 737 Echocardiographic screening for bronchopulmonary dysplasia associated pulmonary hypertension: when, how often, and does it impact outcomes? The American Journal Of The Medical Sciences 2024, 367: s461-s462. DOI: 10.1016/s0002-9629(24)00787-0.Peer-Reviewed Original Research
2023
Interdependence in the Cardiorespiratory Network of Preterm Infants with Pulmonary Hypertension Using Mutual Information Analysis
Ramanand P, Indic P, Gentle S, Ambalavanan N. Interdependence in the Cardiorespiratory Network of Preterm Infants with Pulmonary Hypertension Using Mutual Information Analysis. 2016 Computing In Cardiology Conference (CinC) 2023, 50: 1-4. DOI: 10.22489/cinc.2023.354.Peer-Reviewed Original ResearchBronchopulmonary dysplasiaPreterm infantsPulmonary hypertensionCardiorespiratory networkComplications of PHHeart ratePH groupMechanisms of disease progressionRespiratory rateDisease progressionPretermInfantsOxygen saturationCardiorespiratory morbidityHypertensionGroupMean delayDysplasiaComplicationsMorbidityInformation based similarity analysis of oxygen saturation recordings to detect Pulmonary hypertension in preterm infants
Ramanand P, Indic P, Gentle S, Ambalavanan N. Information based similarity analysis of oxygen saturation recordings to detect Pulmonary hypertension in preterm infants. Biomedical Signal Processing And Control 2023, 86: 105358. PMID: 37692106, PMCID: PMC10487283, DOI: 10.1016/j.bspc.2023.105358.Peer-Reviewed Original ResearchBronchopulmonary dysplasiaPulmonary hypertensionPreterm infantsClinical course of infantsDetect pulmonary hypertensionCourse of infantsPrevalence of PHManagement of PHOxygen saturation recordingsAssociated with multiple morbiditiesRisk of mortalityOxygen saturation dataAmerican Heart AssociationPH diagnosisClinical courseRespiratory deteriorationConsensus guidelinesInfant groupLung diseaseHeart AssociationComplex cardiovascular conditionsRisk factorsOxygen saturationInfantsFive-minute segmentsHeterogeneity of Treatment Effects of Hydrocortisone by Risk of Bronchopulmonary Dysplasia or Death Among Extremely Preterm Infants in the National Institute of Child Health and Human Development Neonatal Research Network Trial
Gentle S, Rysavy M, Li L, Laughon M, Patel R, Jensen E, Hintz S, Ambalavanan N, Carlo W, Watterberg K, Laptook A, Keszler M, Vohr B, Hensman A, Vieira E, St. Pierre L, Burke R, Alksinis B, Caskey M, Hoffman L, Johnson K, Keszler M, Knoll A, Leach T, Little E, McGowan E, Stephens B, Watson V, Hibbs A, Walsh M, Wilson-Costello D, Newman N, Bhola M, Payne A, Siner B, Yalcinkaya G, Truog W, Kilbride H, Gauldin C, Pallotto E, Holmes A, Johnson K, Scott A, Poindexter B, Schibler K, Merhar S, Yolton K, Grisby C, Beiersdorfer T, Cahill T, Dudley J, Gratton T, Kirker K, Thompson J, Wuertz S, Polin R, Cotton M, Goldberg R, Malcolm W, Goldstein R, Finkle J, Ashley P, Fisher K, Gustafson K, Mago-Shah D, Warren M, Bose C, Bernhardt J, Bose G, Wereszczak J, Warner D, Clark C, Kicklighter S, Bentley A, Edwards L, Rhodes-Ryan G, White D, Carlton D, Stoll B, Hale E, Loggins Y, Bottcher D, Carter S, Kendrick-Allywood S, Mulligan LaRossa M, Mackie C, Smikle G, Comerford L, Laursen J, Sanders A, Maitre N, Adams-Chapman I, Bremer A, Wilson Archer S, Higgins R, Tyson J, Khan A, Kennedy K, Mosquera R, Duncan A, McDavid G, Alaniz N, Allain E, Arldt-McAlister J, Sana Boral D, Burson K, Dempsey A, Eason E, Evans P, Garcia C, Green C, Hall D, Jiminez M, John J, Jones P, Lillie M, Martin K, Martin S, Mason C, McKee S, Poe M, Rennie K, Rodgers S, Siddiki S, Sperry D, Stephens E, Pierce Tate P, Wright S, Sanchez P, Nelin L, Jadcherla S, Slaughter J, Luzader P, Burkhardt S, Carey H, Chao M, Clark E, Fearns E, Fortney C, Fowler A, Grothause J, Gutentag J, Hague C, McCool J, Nelin M, Park C, Pietruszewski L, Purnell J, Shadd J, Small K, Stein M, Sullivan M, Sullivan R, Timan C, Yeates K, Yoseff-Salameh L, Keim S, Newton J, Levengood K, Batterson N, Rice C, Moallem M, Harmon H, Das A, Wallace D, Banna C, Gantz M, O'Donnell Auman J, Crawford M, Gabrio J, Leblond D, Newman J, Petrie Huitema C, vonLehmden A, Zaterka-Baxter K, Li L, Van Meurs K, Stevenson D, Chock V, Ball M, Bentley B, Chitkara R, Davis A, DeAnda M, DeBattista A, Earhart B, Huffman L, Krueger C, Lucash R, Proud M, Hitchner Reichert E, Sivakumar D, Taylor H, Weiss H, Peralta-Carcelen M, Collins M, Cosby S, Biasini F, Domnanovich K, McNair T, Phillips V, Whitley S, York Chapman S, Devaskar U, Chanlaw T, Geller R, Garg M, Purdy I, Bell E, Colaizy T, Widness J, Brumbaugh J, Johnson K, Walker J, Goeke C, Schmelzel M, Eastman D, Baack M, Meyer L, Hogden L, Henning M, Elenkiwich C, Broadbent M, Van Muyden S, Ellsbury D, Campbell D, Tud T, Fuller J, Beauman S, Backstrom Lacy C, Ruffner Hanson M, Hartenberger C, Kuan E, Lowe S, Sokol G, Papile L, Harmon H, Hines A, Lytle C, Herron D, Gunn S, Smiley L, Dawn Wilson L, DeMauro S, Schmidt B, Eichenwald E, Kirpalani H, Abbasi S, Mancini T, Chaudhary A, Cucinotta D, Bernbaum J, Freeman Duncan A, Dysart K, Gerdes M, Hurt H, Snyder J, Ziolkowski K, D'Angio C, Guillet R, Myers G, Binion K, Chess P, Fallone C, Farooq O, Kent A, Maffett D, Merzbach J, Orme C, Sacilowski M, Sabaratnam P, Scorsone A, Wadkins H, Wynn K, Yost K, Reynolds A, Lakshminrusimha S, Chandrasekharan P, Guilford S, Hartley-McAndrews M, Williams A, Zorn W, Li E, Donato J, McKee K, Coleman K, Bean S, Coleman C, Horihan C, Wyckoff M, Brion L, Heyne R, Vasil D, Adams S, Chen L, De Leon M, Eubanks F, Guzman A, Heyne E, Lee L, Madden L, McDougald E, Pavageau L, Sepulveda P, Twell Boatman C, Tolentino-Plata K, Vera A, Waterbury J, Yoder B, Ohls R, Baserga M, Winter S, Minton S, Sheffield M, Rau C, Baker S, Burnett J, Christensen S, Cole Bledsoe L, Cunningham S, Davis B, Elmont J, Hall B, Loertscher M, Marchant T, Maxon E, McGrath K, Mickelsen H, Morshedzadeh G, Parry D, Reich B, Schaefer S, Stout K, Stuart A, Weaver-Lewis K, Woodbury K, Shankaran S, Chawla S, Natarajan G, Sood B, Bara R, Agarwal P, Bajaj M, Childs K, February M, Goldston L, Johnson M, Panaitescu B, Hinz Woldt E, Barks J, Carlson M, Christensen M, White D, Wiggins S. Heterogeneity of Treatment Effects of Hydrocortisone by Risk of Bronchopulmonary Dysplasia or Death Among Extremely Preterm Infants in the National Institute of Child Health and Human Development Neonatal Research Network Trial. JAMA Network Open 2023, 6: e2315315. PMID: 37256621, PMCID: PMC10233424, DOI: 10.1001/jamanetworkopen.2023.15315.Peer-Reviewed Original ResearchConceptsSevere neurodevelopmental impairmentExtremely preterm infantsEffect of hydrocortisoneBronchopulmonary dysplasiaNeurodevelopmental impairmentNational Institute of Child HealthInstitute of Child HealthRandomized clinical trialsBaseline riskPreterm infantsGestational ageFollow-upQuartile 4Reduced rates of bronchopulmonary dysplasiaHuman Development Neonatal Research NetworkQuartile 1Clinical trialsMonths of corrected ageRate of bronchopulmonary dysplasiaRate of neurodevelopmental impairmentRisk of bronchopulmonary dysplasiaRelative riskDay of hydrocortisoneNeonatal Research NetworkTreatment groupsThyroid hormone modulates hyperoxic neonatal lung injury and mitochondrial function
Vamesu B, Nicola T, Li R, Hazra S, Matalon S, Kaminski N, Ambalavanan N, Kandasamy J. Thyroid hormone modulates hyperoxic neonatal lung injury and mitochondrial function. JCI Insight 2023, 8: e160697. PMID: 36917181, PMCID: PMC10243814, DOI: 10.1172/jci.insight.160697.Peer-Reviewed Original ResearchConceptsUmbilical cord-derived mesenchymal stem cellsNeonatal lung injuryMild bronchopulmonary dysplasiaSevere bronchopulmonary dysplasiaBronchopulmonary dysplasiaLung injuryELBW infantsThyroid hormonesLung homogenatesMitochondrial dysfunctionTotal T4Newborn miceLow birth weight infantsMitochondrial functionNeonatal hyperoxic lung injuryPeroxisome proliferator-activated receptor γ coactivator 1αProliferator-activated receptor γ coactivator 1αHyperoxic lung injuryReceptor γ coactivator 1αLow total T4Murine lung fibroblastsΓ coactivator 1αNeonatal hypothyroxinemiaWeight infantsPulmonary fibrosisPatent Ductus Arteriosus and Development of Bronchopulmonary Dysplasia-associated Pulmonary Hypertension.
Gentle S, Travers C, Clark M, Carlo W, Ambalavanan N. Patent Ductus Arteriosus and Development of Bronchopulmonary Dysplasia-associated Pulmonary Hypertension. American Journal Of Respiratory And Critical Care Medicine 2023, 207: 921-928. PMID: 36378949, PMCID: PMC10111998, DOI: 10.1164/rccm.202203-0570oc.Peer-Reviewed Original ResearchConceptsBPD-associated pulmonary hypertensionPatent ductus arteriosusDuctus arteriosus patencyPreterm infantsBronchopulmonary dysplasiaPostnatal dayDuctus arteriosusPulmonary hypertensionRespiratory supportModerate to large patent ductus arteriosusBronchopulmonary dysplasia-associated pulmonary hypertensionPreterm infants of gestational ageInfants of gestational ageRetrospective case-control studyEvolving bronchopulmonary dysplasiaExtremely preterm infantsCase-control studyModifiable risk factorsGestational ageDuctal patencyComposite outcomeControl subjectsRisk factorsInfantsPatencyIntermittent Hypoxemia and Bronchopulmonary Dysplasia with Pulmonary Hypertension in Preterm Infants.
Gentle S, Travers C, Nakhmani A, Indic P, Carlo W, Ambalavanan N. Intermittent Hypoxemia and Bronchopulmonary Dysplasia with Pulmonary Hypertension in Preterm Infants. American Journal Of Respiratory And Critical Care Medicine 2023, 207: 899-907. PMID: 36449386, PMCID: PMC10111996, DOI: 10.1164/rccm.202203-0580oc.Peer-Reviewed Original ResearchConceptsBronchopulmonary dysplasia-associated pulmonary hypertensionIntermittent hypoxemiaHypoxemic eventsReceiver Operating CharacteristicPreterm infantsPulmonary hypertensionControl subjectsWeeks 6 daysExtremely preterm infantsWeeks 0 daysHigher risk of deathIdentification of infantsCase-control studyRisk of deathBronchopulmonary dysplasiaDesaturation frequencyEchocardiographic dataPostnatal dayBedside biomarkersIH eventsHigh riskInfantsHypoxemiaHypertensionLong duration
2022
A review and guide to nutritional care of the infant with established bronchopulmonary dysplasia
Miller A, Curtiss J, Taylor S, Backes C, Kielt M. A review and guide to nutritional care of the infant with established bronchopulmonary dysplasia. Journal Of Perinatology 2022, 43: 402-410. PMID: 36494567, DOI: 10.1038/s41372-022-01578-0.Peer-Reviewed Original ResearchConceptsBronchopulmonary dysplasiaNutritional careCommon long-term morbidityIncidence of BPDLong-term pulmonary functionEnteral nutrition managementLong-term morbidityExcess weight gainPostnatal growth failureBPD preventionPreterm nutritionPulmonary functionNeurodevelopmental outcomesPremature birthChronic diseasesFavorable outcomeLung growthGrowth failureHigh riskClinical experienceComprehensive centerInfantsWeight gainNutrition managementDysplasiaSafety and Efficacy of Early Vitamin D Supplementation in Critically Ill Extremely Preterm Infants: An Ancillary Study of a Randomized Trial
Aristizabal N, Holder MP, Durham L, Ashraf AP, Taylor S, Salas AA. Safety and Efficacy of Early Vitamin D Supplementation in Critically Ill Extremely Preterm Infants: An Ancillary Study of a Randomized Trial. Journal Of The Academy Of Nutrition And Dietetics 2022, 123: 87-94. PMID: 35728797, DOI: 10.1016/j.jand.2022.06.012.Peer-Reviewed Original ResearchConceptsVitamin D deficiencyIU/day vitamin DVitamin D dosesVitamin DD deficiencyIU groupBronchopulmonary dysplasiaAncillary studiesD dosesEarly vitamin D supplementationRepeated-measures mixed modelPredictive riskIU/daySevere bronchopulmonary dysplasiaVitamin D doseVitamin D supplementationMean birth weightPostnatal day 28Postnatal day 1D supplementationEfficacy outcomesPlacebo groupCritically IllPreterm infantsNeonatal unitType 2 immune polarization is associated with cardiopulmonary disease in preterm infants
Lao J, Bui C, Pang M, Cho S, Rudloff I, Elgass K, Schröder J, Maksimenko A, Mangan N, Starkey M, Skuza E, Sun Y, Beker F, Collins C, Kamlin O, König K, Malhotra A, Tan K, Theda C, Young M, McLean C, Wilson N, Sehgal A, Hansbro P, Pearson J, Polo J, Veldman A, Berger P, Nold-Petry C, Nold M. Type 2 immune polarization is associated with cardiopulmonary disease in preterm infants. Science Translational Medicine 2022, 14: eaaz8454. PMID: 35385341, DOI: 10.1126/scitranslmed.aaz8454.Peer-Reviewed Original ResearchConceptsPreterm infantsBronchopulmonary dysplasiaIL-13CD3<sup>+</sup>CD4<sup>+</sup> T cellsInterleukin-4BPD-associated pulmonary hypertensionMaternal magnesium sulfate therapyCD4<sup>+</sup> T cellsCardiopulmonary diseaseMagnesium sulfate therapyType 2 mediatorsHealthy term infantsType 2 polarizationType 2 cytokinesHepatitis B vaccineMultiple therapeutic approachesTerm infantsPulmonary hypertensionDisease in vivoT cellsLung inflammationYounger patientsIL-5B vaccineHigh treatment costsCorrection: Duration of noninvasive respiratory support and risk for bronchopulmonary dysplasia or death
Gentle S, Carper B, Laughon M, Jensen E, Williams A, Travers C, Ambalavanan N, Lal C, Carlo W. Correction: Duration of noninvasive respiratory support and risk for bronchopulmonary dysplasia or death. Journal Of Perinatology 2022, 42: 550-550. PMID: 35314760, DOI: 10.1038/s41372-022-01364-y.Peer-Reviewed Original ResearchDuration of noninvasive respiratory supportNoninvasive respiratory supportBronchopulmonary dysplasiaRespiratory supportCommentary on “compatibility of rapid enteral feeding advances and noninvasive ventilation in preterm infants—an observational study”
Buck CO, Taylor SN. Commentary on “compatibility of rapid enteral feeding advances and noninvasive ventilation in preterm infants—an observational study”. Pediatric Pulmonology 2022, 57: 1113-1116. PMID: 35191225, DOI: 10.1002/ppul.25867.Peer-Reviewed Original ResearchConceptsExtremely preterm infantsPreterm infantsBronchopulmonary dysplasiaRapid enteral feeding advancementEnteral feeding advancementFull enteral feedingVery preterm infantsFeeding advanceFeeding advancementEnteral feedingMultifactorial pathogenesisNoninvasive ventilationNutritional supportCritical careObservational studyInfantsPotential rolePotential benefitsDysplasiaPathogenesisCareExclusive Maternal Milk Compared With Exclusive Formula on Growth and Health Outcomes in Very-Low-Birthweight Preterm Infants: Phase II of the Pre-B Project and an Evidence Analysis Center Systematic Review
Taylor SN, Fenton TR, Groh-Wargo S, Gura K, Martin CR, Griffin IJ, Rozga M, Moloney L. Exclusive Maternal Milk Compared With Exclusive Formula on Growth and Health Outcomes in Very-Low-Birthweight Preterm Infants: Phase II of the Pre-B Project and an Evidence Analysis Center Systematic Review. Frontiers In Pediatrics 2022, 9: 793311. PMID: 35280446, PMCID: PMC8913886, DOI: 10.3389/fped.2021.793311.Peer-Reviewed Original ResearchExclusive preterm formulaVLBW preterm infantsPreterm infantsMaternal milkSystematic reviewPreterm formulaEvidence Analysis Center Systematic ReviewHealth outcomesLow birthweight preterm infantsLow-quality evidenceBirthweight preterm infantsMaternal milk intakeAcademy of NutritionHuman milk researchObservational study designPreferred Reporting ItemsMeta-Analyses (PRISMA) checklistRisk of selectionFormula intakeBronchopulmonary dysplasiaCircumference gainPooled analysisPROSPERO IDObservational studyMilk intakeDuration of noninvasive respiratory support and risk for bronchopulmonary dysplasia or death
Gentle S, Carper B, Laughon M, Jensen E, Williams A, Travers C, Ambalavanan N, Lal C, Carlo W. Duration of noninvasive respiratory support and risk for bronchopulmonary dysplasia or death. Journal Of Perinatology 2022, 42: 454-460. PMID: 35034096, PMCID: PMC9007818, DOI: 10.1038/s41372-021-01269-2.Peer-Reviewed Original ResearchConceptsNoninvasive respiratory supportDuration of noninvasive respiratory supportBronchopulmonary dysplasiaRespiratory supportAssociated with bronchopulmonary dysplasiaDevelopment of bronchopulmonary dysplasiaRetrospective study of infantsStudy of infantsPreterm infantsWeeks gestationPropensity score matchingNoninvasive supportMedian durationRetrospective studyPotential confoundersIllness severityScore matchingInfantsPropensity scoreGestationDysplasiaDeathDurationAssociationPreterm
This site is protected by hCaptcha and its Privacy Policy and Terms of Service apply